Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. - Wikidata - wikimedia - TriplyDB

Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation.

Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation.

http://www.wikidata.org/entity/Q36380599

about

Lipid body-phagosome interaction in macrophages during infectious diseases: host defense or pathogen survival strategy?Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production The cyclooxygenases Host Lipid Bodies as Platforms for Intracellular Survival of Protozoan Parasites The internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomography The molecular biology and regulation of 5-lipoxygenase Biology and pathobiology of lipid droplets and their potential role in the protection of the organ of Corti.Induction of endothelial cell cytoplasmic lipid bodies during hypoxia.Novel translocation responses of cytosolic phospholipase A2alpha fluorescent proteins.HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.Phospholipase A2 enzymes in eicosanoid generation.Lipid bodies in inflammatory cells: structure, function, and current imaging techniques.Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production.Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants.Unraveling the complexity of lipid body organelles in human eosinophils.Not just fat: the structure and function of the lipid droplet.Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies.Mechanisms of eosinophil cytokine release.Mechanisms of leukocyte lipid body formation and function in inflammation.Insulin-containing lipogenic stimuli suppress mast cell degranulation potential and up-regulate lipid body biogenesis and eicosanoid secretion in a PPARγ-independent manner.Lipid droplets in leukocytes: Organelles linked to inflammatory responses Comparative Proteomic Study of Fatty Acid-treated Myoblasts Reveals Role of Cox-2 in Palmitate-induced Insulin Resistance.Lipid droplets: a classic organelle with new outfits Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.Eosinophils in innate immunity: an evolving story.Eosinophilic airway inflammation in COPD Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection Allergic challenge-elicited lipid bodies compartmentalize in vivo leukotriene C4 synthesis within eosinophils.Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies.Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling.A mechanism of benefit of soy genistein in asthma: inhibition of eosinophil p38-dependent leukotriene synthesis.Leukocyte lipid bodies - Biogenesis and functions in inflammation Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.Eosinophil recruitment and activation: the role of lipid mediators.The intriguing ultrastructure of lipid body organelles within activated macrophages.The interrelationship between leukotriene B4 and leukotriene-A4-hydrolase in collagen/adjuvant-induced arthritis in rats.Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.

P2860

Q21131401-4D6CE856-141B-40F0-93C6-CAFB2E562590 Q24597517-57708857-F1B7-4EE3-88B3-C3701ABAEF81 Q24678254-04AD117C-4D72-43FC-A8A3-CC71E8AE6D79 Q24801433-6FF7BA0F-C782-4643-84B4-D7A90151291C Q26747388-A1A054B3-D705-4B4F-AF20-CEABE6252F96 Q27333495-5094F691-8156-443D-BB53-CE3C081A3049 Q28144667-73BDE8D9-8286-402C-8240-76D9857BB3AC Q30358679-3E93B36D-2D46-476D-8792-803EF86D1EC8 Q31722778-0E09552B-9394-4D0B-B3D8-3793EB343987 Q33327848-85415D3F-BAE7-41C6-B2A7-4604154B6E15 Q33361587-4DA19A5A-0389-4BF4-B8E5-83EE647EEA76 Q33595339-A7E4308E-0D69-4F57-905C-E4D65F0E2517 Q33669090-87B9F515-97EC-4C1E-B38C-A66CE97BCDB1 Q33790580-264EB611-35B6-49F6-BCC5-688A480D448A Q34026238-FE9755C9-FADF-458A-BF30-EF901D6399FA Q34255783-0F7E176A-D704-4F35-85FC-6B89772DC893 Q34310922-AF3A0AF0-7810-443C-8AD0-DC761D7CC836 Q34341337-76333919-F69E-43BF-A070-9E0E049E0C7E Q34578014-D6ACFB24-C993-4122-A6B8-3E473624085F Q35765061-C0CF626E-6D3B-42FA-8690-ADA0C8209AE7 Q36165871-3CCC18BE-07F3-4C08-B16F-02E552616312 Q36165879-D38FDE7D-C0F5-44D6-896B-B2EF0E8173A9 Q36188874-4F267DAB-BE73-47C5-8F9B-747BA0064EDB Q36553849-48D6FD19-AB0C-4DB5-84C5-8C935877414F Q36602222-C9615609-CD0B-475C-95CE-A2C88445CBAE Q36801009-DF2005E5-6C26-4825-BF5C-BD9C0D5A5966 Q36902259-66410C18-6D39-43BB-A3EE-1624B220B731 Q36921021-486FB626-66EF-4347-81C9-F712BCBADB2E Q37018920-C8FECC33-CD56-4975-810D-996F5494F74A Q37215305-67522B30-8020-43FB-92CF-613050774B40 Q37273858-D7F5278F-59BE-454E-8508-4E65F31A822E Q37274184-F174481F-EB4C-4DD0-AA39-6F3B9051ADF3 Q37349574-567F628D-49F3-4DE7-BA50-F35C402431D2 Q37414633-1CEC42C6-BDA0-4C16-8A41-9F5E9B26A0F5 Q37471003-4C8FCBD1-D802-49A6-95CC-13F8C3C2FFCB Q37644800-AF3A935E-A1D1-4C8B-8802-D4C8208F11CD Q38092645-2CD8CCA4-D92E-421D-8CD7-99A7E4286B80 Q38208513-71F0529E-3653-405C-9A98-A9BBA31EF17A Q38256449-8D3D0BDE-5C7A-4AE3-AC3C-E306FC916488 Q38854446-107A5994-34FF-4DBB-8B53-AC4AAF04FEA7

P2860

Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation.

http://www.wikidata.org/entity/Q36380599

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@ast

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@en

type

label

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@ast

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@en

prefLabel

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@ast

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@en

P1433

Q36380599-63C4929D-3AE5-477A-B2C2-AF85529B6DA8

P1476

Q36380599-4C09E128-7A7D-4F52-81B6-BE73FA446A36

P2093

Q36380599-28A7ACB4-E8CF-4422-8FA8-6A0BD30EFB7B

Q36380599-3C5A5187-9511-44B8-98A9-BE8484DE5D8C

Q36380599-830D4BDD-96EE-44A3-B643-0A29EED3840A

Q36380599-92D37DD6-8A22-4C0F-B9FD-FE52A654FEA8

Q36380599-A238FCEE-0AB8-4DB1-B3D1-68FD89EA0945

Q36380599-ED29AB4E-CCA3-4026-B5C5-51C28458A0CD

P2860

Q36380599-023DC678-A163-4068-BC7B-9CC8EB71E530

Q36380599-102EC921-7DB8-4402-8FEF-F3AFE9FABB44

Q36380599-15B9614A-4CEE-4B51-8CF5-791C74E7F067

Q36380599-1D3692C3-5211-4EE1-9F64-A0CFD260FEFB

Q36380599-1F20E5B3-77E6-467B-8B18-FA85508E0A63

Q36380599-3208DA8E-7220-4158-8648-799DA22B8CBE

Q36380599-3DC8CB4E-01AB-465B-828F-FE2117F32056

Q36380599-4E8FC3DD-C7AE-41A6-8CCE-6FF5B87D866D

Q36380599-5ABC4398-03B0-434E-855A-02A9F213BFFA

Q36380599-664254B9-BD30-4D8B-B716-7C1364B64CDB

P304

Q36380599-B59A3A2D-F8D9-4E70-A309-182FD5D3E3CC

P31

Q36380599-B827B0C1-213C-4A1C-9494-628F5AC5AF6E

P356

Q36380599-EE2C0790-3D93-4728-84CF-4656AB15135E

P407

Q36380599-1F128453-6420-4D7E-8959-0EE54B53C742

P433

Q36380599-1DB33BF5-1411-4789-A843-3E3894002452

P478

Q36380599-C1C3C35A-0DB3-499A-8140-895C97267FA7

P577

Q36380599-FF3CE5CB-2187-453E-9CD0-871FDBD878A3

P5875

Q36380599-C9B40E76-5F01-475F-B176-1FCFF6050145

P698

Q36380599-E31A4FFB-A2DB-492D-9E62-278BABE1280F

P932

Q36380599-DD18D89A-1B56-40D4-B296-4814C6A6D451

P356

P1433

Journal of Experimental Medicine

P1476

Eosinophil lipid bodies: speci ...... enhanced eicosanoid formation.

@en

P2093

A M Dvorak

http://www.w3.org/2001/XMLSchema#string

E S Morgan

http://www.w3.org/2001/XMLSchema#string

J F Penrose

http://www.w3.org/2001/XMLSchema#string

P F Weller

http://www.w3.org/2001/XMLSchema#string

P T Bozza

http://www.w3.org/2001/XMLSchema#string

W Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Purification of human leukotriene C4 synthase

Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids

Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells

5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation

The role of leukotrienes in inflammation.

P304

909-920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.186.6.909

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13927355

http://www.w3.org/2001/XMLSchema#string

P698

9294145

http://www.w3.org/2001/XMLSchema#string

P932

2199047

http://www.w3.org/2001/XMLSchema#string